SYMPOSIA ABSTRACTS
Symposia Session X
S-10
DABIGATRAN ETEXILATE, A NOVEL,
REVERSIBLE, ORAL DIRECT THROMBIN INHIBITOR: PRECLINICAL PROFILE AND CLINICAL
EVIDENCE
| S-10/1 | Preclinical
Profilet of Dabigatran J. Van Ryn (Germany) |
| S-10/2 | Clinical Evidences on
Dabigatran M. G. Franzosi (Milano) |